Inhibitory effect of some quinoline, phthalazine, and coumarin derivatives on glucose-6-phosphate dehydrogenase in vitro.
D001667:Binding, Competitive; D002738:Chloroquine / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology*; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors*; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D006830:Hydralazine / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010619:Phenazines / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D010659:Phenylhydrazines / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D013424:Sulfanilamides / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology; D015003:Yeasts / Q000201:enzymology
D003374:Coumarins; D006571:Heterocyclic Compounds; D010619:Phenazines; D010659:Phenylhydrazines; D011725:Pyridines; D011804:Quinolines; D013424:Sulfanilamides; D009675:Novobiocin; D006830:Hydralazine; D014859:Warfarin; D002738:Chloroquine; D011803:Quinine; D005954:Glucosephosphate Dehydrogenase; D011796:Quinacrine; D011802:Quinidine; D010624:Phenelzine; D011339:Probenecid; D007538:Isoniazid